scanX
Dr Reddys Laboratories
add_icon

Dr Reddys Laboratories

1,232.20
+20.30
(1.68%)
Market Cap
1,02,844.71 Cr
PE Ratio
18.32
Volume
19,31,448.00
Day High - Low
1,236.80 - 1,208.80
52W High-Low
1,379.70 - 1,061.65
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,02,844.71 Cr
EPS
67.89
PE Ratio
18.32
PB Ratio
2.81
Book Value
431.48
EBITDA
9,644.40
Dividend Yield
0.66 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
16.87
Debt to Equity
0.11
Analyst Rating and Forecast
- By Refinitiv from38 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+47.37 %
+47.37 %
Hold
Hold+23.68 %
+23.68 %
Sell
Sell+28.95 %
+28.95 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Dr. Reddy's Files Q4 FY26 SEBI Compliance Certificate1 day ago
Dr. Reddy's Laboratories submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26, confirming proper dematerialization processes through registrar Bigshare Services.
negative
Morgan Stanley Cuts Dr. Reddy's Target to ₹1,2592 days ago
Morgan Stanley maintains Equal Weight rating on Dr. Reddy's with reduced target price of ₹1,259 from ₹1,285, citing earnings downgrades and North America revenue challenges from gRevlimid phase-out.
neutral
Dr. Reddy's sells Svaas Wellness for ₹2.23 crore2 days ago
Dr. Reddy's Laboratories divests its wholly owned subsidiary Svaas Wellness Limited to Enspirited Technology Services for ₹2.23 crore. The subsidiary contributed 0.09% to consolidated turnover in FY 2025.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,654.90
#1 3,97,065.94
37.62
#1 54,729.00
9.71
#1 10,980
16.07
43.58
Divis Laboratories
6,116.50
1,62,373.86
63.80
9,712.00
18.67
2,191
-1.02
42.95
Torrent Pharmaceuticals
4,155.20
1,40,630.85
60.97
11,539.40
6.99
1,911
26.24
43.04
Lupin
2,333.80
1,06,664.75
22.48
22,909.50
13.74
3,306
#1 37.44
50.85
Dr Reddys Laboratories
1,232.20
#5 1,02,844.71
#2 18.32
#2 33,741.20
#4 16.73
#2 5,725
#9 -15.28
40.81
Cipla
1,229.50
99,316.63
21.81
28,409.50
7.12
5,291
-57.18
38.91
Zydus Life Science
915.40
92,110.66
#1 18.06
23,511.00
18.55
4,615
-0.32
53.73
Mankind Pharma
2,079.00
85,822.17
47.03
12,744.20
#1 20.90
2,007
7.65
48.44
Aurobindo Pharma
1,349.40
78,373.37
22.33
32,345.60
9.43
3,484
7.59
64.24
Alkem Laboratories
5,440.00
65,043.36
26.50
13,458.30
3.70
2,216
1.90
50.31
Growth Rate
Revenue Growth
16.73 %
Net Income Growth
2.64 %
Cash Flow Change
2.19 %
ROE
-14.54 %
ROCE
-13.11 %
EBITDA Margin (Avg.)
-6.42 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
3,887
3,813
4,061
4,030
3,841
3,302
3,630
3,747
3,575
3,354
3,578
3,849
3,580
3,779
3,937
3,961
4,116
4,290
4,867
4,469
4,516
4,512
4,955
5,015
4,829
5,044
5,993
5,394
5,569
6,079
6,361
6,835
6,443
6,917
7,199
7,434
7,284
7,866
8,330
8,513
9,034
8,836
9,135
8,998
Expenses
3,271
2,765
2,888
2,996
3,313
2,855
2,989
2,859
3,021
3,010
2,890
3,041
2,990
2,968
3,058
3,060
3,211
3,117
3,749
4,686
3,500
3,305
3,755
4,403
3,715
4,211
4,427
4,123
5,024
4,292
4,433
4,851
4,781
4,696
4,894
5,214
5,283
5,566
5,962
6,108
6,531
6,399
6,818
6,866
EBITDA
616
1,048
1,173
1,034
528
447
640
888
553
344
687
808
590
812
879
901
905
1,174
1,118
-217
1,016
1,207
1,200
613
1,114
833
1,566
1,271
545
1,787
1,928
1,983
1,662
2,221
2,305
2,220
2,001
2,300
2,368
2,405
2,503
2,437
2,317
2,132
Operating Profit %
15 %
26 %
28 %
25 %
12 %
12 %
17 %
23 %
15 %
9 %
18 %
20 %
15 %
20 %
19 %
21 %
20 %
19 %
22 %
-7 %
21 %
25 %
23 %
11 %
21 %
14 %
23 %
23 %
8 %
18 %
30 %
28 %
24 %
30 %
29 %
28 %
25 %
27 %
26 %
27 %
23 %
25 %
23 %
21 %
Depreciation
0
203
224
235
277
244
262
267
254
259
270
272
276
279
279
290
287
289
313
287
274
292
317
311
309
284
294
294
293
302
309
324
316
353
376
374
368
381
397
471
455
476
505
521
Interest
23
28
22
16
17
15
13
16
20
22
22
17
18
20
21
24
25
30
30
15
23
23
25
19
30
19
23
22
32
35
31
42
35
37
35
39
59
60
76
82
66
83
91
94
Profit Before Tax
593
831
960
733
273
199
396
622
337
81
409
547
314
529
599
601
606
869
786
-506
736
901
873
295
815
556
1,273
974
259
1,468
1,614
1,638
1,329
1,850
1,917
1,829
1,605
1,883
1,917
1,874
2,005
1,905
1,745
1,543
Tax
74
184
185
147
150
45
87
130
-1
14
103
244
42
53
81
101
151
193
-321
33
-45
306
101
267
258
175
277
265
162
279
499
394
369
445
435
448
295
490
576
470
419
495
408
354
Net Profit
519
647
775
586
123
154
309
492
338
67
305
303
272
476
518
500
455
677
1,107
-538
781
595
772
28
557
380
996
709
97
1,189
1,114
1,244
960
1,405
1,482
1,381
1,310
1,392
1,342
1,404
1,587
1,410
1,337
1,190
EPS in ₹
30.45
37.99
45.42
34.34
7.19
9.06
18.64
29.72
20.38
4.02
18.42
18.25
16.39
28.69
31.22
30.16
27.45
40.81
66.78
-32.48
47.12
35.87
46.54
1.68
33.61
22.95
60.03
42.75
5.84
71.64
67.13
74.91
57.79
84.55
89.09
82.94
78.66
83.61
75.40
16.97
19.12
17.04
16.18
14.53
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
49,427
Fixed Assets
5,377
6,563
6,931
6,968
7,191
6,850
8,206
8,122
9,219
10,426
18,226
Current Assets
11,877
11,794
9,684
10,498
11,110
12,599
14,550
17,782
20,426
24,805
25,018
Capital Work in Progress
529
772
3,325
3,471
2,934
1,535
1,565
1,293
1,030
1,419
2,466
Investments
2,102
3,833
2,110
2,298
2,587
2,678
2,212
2,616
4,986
4,931
4,051
Other Assets
10,590
9,216
9,452
9,808
9,754
12,162
14,634
17,716
17,050
22,088
24,684
Total Equity & Liabilities
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
49,427
Current Liabilities
6,821
6,347
8,420
6,894
5,897
7,214
8,104
9,766
8,572
9,588
13,034
Non Current Liabilities
1,923
1,467
1,135
3,079
2,545
412
871
769
427
1,021
2,465
Total Equity
9,853
12,570
12,262
12,572
14,024
15,599
17,642
19,212
23,286
28,255
33,927
Reserve & Surplus
9,768
12,485
12,179
12,489
13,994
15,616
17,755
19,289
23,330
28,171
33,466
Share Capital
85
85
83
83
83
83
83
83
83
83
83
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-280
-47
-114
-124
-31
-27
1,286
3
-907
133
749
Investing Activities
-2,370
-1,610
-1,890
-1,483
-769
-495
-2,255
-2,565
-4,109
-4,034
-5,785
Operating Activities
2,524
3,263
2,144
1,803
2,870
2,984
3,570
2,811
5,888
4,543
4,643
Financing Activities
-433
-1,700
-369
-444
-2,133
-2,516
-30
-242
-2,686
-376
1,891
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
26.74 %
26.73 %
26.72 %
26.72 %
26.72 %
26.71 %
26.71 %
26.70 %
26.70 %
26.69 %
26.66 %
26.65 %
26.65 %
26.65 %
26.64 %
26.64 %
26.64 %
26.64 %
26.64 %
26.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
42.21 %
0.00 %
44.49 %
42.27 %
41.75 %
40.08 %
37.29 %
36.36 %
35.52 %
33.20 %
DIIs
14.25 %
15.08 %
20.92 %
21.95 %
24.46 %
24.95 %
24.47 %
23.38 %
23.05 %
21.99 %
21.04 %
16.21 %
18.31 %
20.73 %
21.48 %
22.90 %
25.62 %
26.74 %
27.98 %
30.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.31 %
7.76 %
8.14 %
8.27 %
8.37 %
8.22 %
8.06 %
7.84 %
7.59 %
7.51 %
7.91 %
8.44 %
8.25 %
8.07 %
8.07 %
8.07 %
8.20 %
8.04 %
7.56 %
7.65 %
Others
50.70 %
50.43 %
44.22 %
43.07 %
40.45 %
40.12 %
40.76 %
42.08 %
42.66 %
43.80 %
2.18 %
48.69 %
2.30 %
2.29 %
2.06 %
2.30 %
2.25 %
2.22 %
2.30 %
2.07 %
No of Share Holders
2,21,107
2,23,309
2,55,720
2,42,376
2,63,803
2,55,300
2,59,271
2,46,788
2,32,715
2,46,769
2,43,445
2,57,794
2,55,500
2,67,694
3,10,403
4,03,669
4,59,605
4,51,929
4,49,216
4,55,243

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 20 20 20 25 25 30 40 40 8 0.00
Dividend Yield (%) 4.81 3.6 3.2 2.77 2.91 3.24 3.25 3.5 0.64 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 May 2026 1,298.90 1,212.35
13 Jul 2021 DIVIDEND Dividend
₹ 25.00 /share
 09 Jul 2021 1,060.40 1,097.91
13 Jul 2022 DIVIDEND Dividend
₹ 30.00 /share
 11 Jul 2022 781.62 896.74
12 Jul 2023 DIVIDEND Dividend
₹ 40.00 /share
 11 Jul 2023 986.65 1,033.17
17 Jul 2024 DIVIDEND Dividend
₹ 40.00 /share
 16 Jul 2024 1,258.69 1,329.21
29 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Jul 2024 1,258.69 1,378.43
27 Jul 2024 SPLIT Split
1:5
 28 Oct 2024 1,378.43 1,378.43
05 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Nov 2024 1,310.23 1,268.30
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jan 2025 1,343.65 1,296.25
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 09 May 2025 1,187.20 1,148.00
10 Jul 2025 DIVIDEND Dividend
₹ 8.00 /share
 10 Jul 2025 1,148.00 1,269.40
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jul 2025 1,325.45 1,240.40
24 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Jul 2025 1,148.00 1,247.40
24 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2025 1,321.70 1,279.40
21 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 21 Jan 2026 1,283.85 1,166.70

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Sale Of Wholly Owned Subsidiary2 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 26, 2026
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 24, 2026
Board Meeting Intimation for Considering The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On March 31 2026Mar 23, 2026
Closure of Trading WindowMar 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 21, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 17, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 12, 2026
Rumour verification - Regulation 30(11)Mar 10, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 10, 2026
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015Mar 06, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Disclosure Under Regulation 30 Of The SEBI Listing RegulationsFeb 24, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 18, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 27, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 21, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 21, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Board Meeting Outcome for Outcome Of Board MeetingJan 21, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 14, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 08, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 01, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Dec 31, 2025
Closure of Trading WindowDec 23, 2025
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On December 31 2025Dec 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 16, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Dec 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 09, 2025
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015Dec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 28, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Nov 26, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Nov 26, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-100000
-2.28%
-2.24%
Nippon India MNC Fund Direct-Growth
0.00%
-90000
-2.72%
-2.58%
Sundaram Multi-Factor Fund Direct-Growth
0.00%
-86641
-1.10%
-0.74%
JM Large & Mid Cap Fund Direct-Growth
0.00%
-49850
-1.58%
-1.52%
The Wealth Company Flexi Cap Fund Direct-Growth
1.81%
28200
1.81%
1.81%
Parag Parikh Large Cap Fund Direct-Growth
0.00%
-17879
-0.57%
0.00%
Nippon India BSE Sensex Next 30 Index Fund Direct-Growth
0.00%
-16948
-3.01%
-2.91%
Kotak Active Momentum Fund Direct-Growth
1.61%
14939
0.15%
1.61%
JioBlackRock Nifty 50 Index Fund Direct-Growth
0.00%
-10874
-0.68%
-0.64%
DSP Nifty Healthcare Index Fund Direct-Growth
0.00%
-10432
-7.81%
-7.91%
Groww Multi Asset Allocation Fund Direct-Growth
0.00%
-8320
-0.27%
-0.96%
Nippon India Nifty 500 Low Volatility 50 Index Fund Direct-Growth
0.00%
-7004
-3.20%
-3.09%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth
0.00%
-6331
-2.03%
-2.01%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-4997
-0.58%
0.00%
SBI Nifty100 Low Volatility 30 Index Fund Direct-Growth
3.32%
-1796
-0.05%
0.12%
Angel One Nifty 50 Index Fund Direct-Growth
0.00%
-1667
-0.68%
-0.64%
Zerodha Nifty 50 Index Fund Direct-Growth
0.00%
-1600
-0.68%
-0.64%
Groww Nifty 50 Index Fund Direct-Growth
0.00%
-1069
-0.68%
-0.64%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-345
-0.40%
-0.38%
UTI Nifty500 Shariah Index Fund Direct-Growth
1.47%
309
0.08%
1.47%
Bajaj Finserv Nifty 50 Index Fund Direct-Growth
0.74%
-185
0.06%
0.10%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.42%
53
0.04%
0.06%
JM Flexicap Fund Direct Plan-Growth
0.00%
0
0.00%
-2.98%
ICICI Prudential Nifty 50 Index Direct Plan-Growth
0.74%
0
0.00%
0.06%
Bandhan Healthcare Fund Direct-Growth
7.12%
0
0.35%
0.37%

Technical Indicators

RSI(14)
Neutral
40.81
ATR(14)
Less Volatile
35.89
STOCH(9,6)
Neutral
23.77
STOCH RSI(14)
Oversold
9.70
MACD(12,26)
Bearish
-9.52
ADX(14)
Strong Trend
27.13
UO(9)
Bearish
44.64
ROC(12)
Downtrend But Slowing Down
-4.91
WillR(14)
Neutral
-68.62
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104